scholarly article | Q13442814 |
P356 | DOI | 10.1227/01.NEU.0000290905.53685.A2 |
P698 | PubMed publication ID | 17881971 |
P2093 | author name string | Ji Ming Wang | |
Wen Zhao | |||
Wanghua Gong | |||
Xiang-dong Zhou | |||
Xue-feng Jiang | |||
Zi-qiang Chen | |||
Qing-liang Wang | |||
Xiu-wu Bian | |||
Jian-hong Chen | |||
Yi-fang Ping | |||
Lin-lin Du | |||
Hua-liang Xiao | |||
Jing-quan Shi | |||
Shi-xin Yang | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 570-8; discussion 578-9 | |
P577 | publication date | 2007-09-01 | |
P1433 | published in | Neurosurgery | Q7002693 |
P1476 | title | Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival | |
P478 | volume | 61 |
Q42545669 | (68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma. |
Q55463442 | A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target. |
Q48347104 | A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion |
Q57174079 | A three-dimensional (3D) organotypic microfluidic model for glioma stem cells - Vascular interactions |
Q35788749 | Adult mouse subventricular zones stimulate glioblastoma stem cells specific invasion through CXCL12/CXCR4 signaling |
Q34200294 | CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma |
Q33677057 | CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment |
Q89805077 | CXCR4 Antagonists as Stem Cell Mobilizers and Therapy Sensitizers for Acute Myeloid Leukemia and Glioblastoma? |
Q41760694 | CXCR4 activation defines a new subgroup of Sonic hedgehog-driven medulloblastoma |
Q42007327 | CXCR4 in Cancer and Its Regulation by PPARgamma |
Q26781915 | CXCR4 in breast cancer: oncogenic role and therapeutic targeting |
Q36675171 | CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors |
Q33464680 | Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival |
Q37222198 | Chemokine signaling in cancer: one hump or two? |
Q34654670 | Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma |
Q90663490 | Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors |
Q37153084 | Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma |
Q49671624 | Expression of CXC-motif-chemokine 12 and the receptor C-X-C receptor 4 in glioma and theeffect on peritumoral brain edema |
Q37175083 | G-protein coupled chemoattractant receptors and cancer |
Q64121793 | Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation |
Q41541275 | Immunoexcitatory mechanisms in glioma proliferation, invasion and occasional metastasis |
Q34787997 | Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CT |
Q37641240 | Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells |
Q37148248 | KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo. |
Q34032023 | Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12. |
Q60938469 | Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer |
Q92237972 | Potential for Nuclear Medicine Therapy for Glioblastoma Treatment |
Q64275194 | Principles of tumorigenesis and emerging molecular drivers of SHH-activated medulloblastomas |
Q36375378 | Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer |
Q34313996 | Receptor "hijacking" by malignant glioma cells: a tactic for tumor progression |
Q35683150 | Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth |
Q50491825 | Survival and Proliferation of Neural Progenitor-Derived Glioblastomas Under Hypoxic Stress is Controlled by a CXCL12/CXCR4 Autocrine-Positive Feedback Mechanism. |
Q38165795 | Systematic review of protein biomarkers of invasive behavior in glioblastoma |
Q36728282 | Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model |
Q35213463 | Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis |
Q64099555 | Targeting the Post-Irradiation Tumor Microenvironment in Glioblastoma via Inhibition of CXCL12 |
Q39724471 | The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells |
Q39886658 | The CXCR4/CXCL12 axis in endometrial cancer. |
Q53154022 | The Clinical Implications of Chemokine Receptor CXCR4 in Grade and Prognosis of Glioma Patients: A Meta-Analysis. |
Q36490004 | The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants |
Q48635543 | The clinical value of serum hepatocyte growth factor levels in patients undergoing primary radiotherapy for glioma: effect on progression-free survival |
Q37321944 | The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis. |
Q38203241 | The role of CXCR4 in highly malignant human gliomas biology: current knowledge and future directions |
Q38089686 | The role of the CXCR4 cell surface chemokine receptor in glioma biology |
Q24628917 | Treating brain tumors with PDE4 inhibitors |
Q92126841 | Tumor Angiogenic Inhibition Triggered Necrosis (TAITN) in Oral Cancer |
Search more.